Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-09

Clinical Trial Update: Fecal Microbiota Transplantation for CRE/VRE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of fecal microbiota transplantation for carrying CRE/VRE related antimicrobial resistance and colonization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Antimicrobial Resistance, Colonization | Phase 2 | Status: COMPLETED